Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 28 of 1,261
  1. US 12364693

    Methods of treating metabolic diseases with fused bicyclic pyrazoles

    Belite Bio, Inc · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  2. US 12364609

    Biomimetic implants

    The Regents of the University of California · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  3. US 12364762

    Biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  4. US 12364764

    Sustained release thermosetting gels comprising sodium channel blockers and the methods of making same

    Pacira Therapeutics, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  5. US 12364775

    Viral vectors for cancer therapy

    Krystal Biotech, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  6. US 12364753

    CD8 binding agents

    Orionis Biosciences, Inc · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  7. US 12365672

    Compounds and their use for the treatment of alpha1-antitrypsin deficiency

    CENTESSA PHARMACEUTICALS (UK) LIMITED · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  8. US 12365688

    Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors

    Revolution Medicines, Inc. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  9. US 12364774

    Nucleic acid molecules and uses thereof for non-viral gene therapy

    BIOVERATIV THERAPEUTICS INC. · Granted Jul 22, 2025 · Expires Jul 17, 2045

    granted
  10. AR 132581

    COMPOSICIÓN INMUNÓGENA ÚTIL PARA LA AUTOADMINISTRACIÓN POR CERDOS

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Jul 16, 2025 · Expires Jul 11, 2045

    granted
  11. US 12357697

    Pharmaceutical compositions comprising bupropion and cysteine

    AXSOME THERAPEUTICS, INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  12. US 12357702

    Peptidic diagnostic compositions

    S. M. DISCOVERY GROUP INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  13. US 12357570

    Chemoembolization agents

    The Regents of the University of California · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  14. US 12358210

    Resin composition for stereolithography

    KURARAY NORITAKE DENTAL INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  15. US 12357640

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  16. US 12358892

    Metalloenzyme inhibitors for treating cancers, Alzheimer's disease, hemochromatosis, and other disorders

    Miralogx LLC · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  17. US 12358879

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  18. US 12357617

    Discovery of novel anti-infectives for gram negative pathogens

    The Regents of the University of California · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  19. US 12357666

    Traditional Chinese herbal plant composition for improving symptoms of liver cancer patients and compatibility method thereof

    The First Hospital of China Medical University · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  20. US 12357599

    Prodrugs of treprostinil

    United Therapeutics Corporation · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  21. US 12357703

    Muscle-targeting complexes comprising an anti-transferin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping

    Dyne Therapeutics, Inc. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  22. US 12358971

    Arena virus monoclonal antibodies and uses

    The Boad of Regents of the University of Texas System · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  23. US 12358896

    LRRK2 inhibitors and methods of making and using thereof

    DENALI THERAPEUTICS INC. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  24. US 12358885

    Substituted n-propylamine fused heterocyclic mescaline derivatives

    Enveric Biosciences Canada Inc. · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.